Assure Holdings Promotes Craig Caviness to Vice President of Corporate Development
26 October 2020 - 11:30PM
Assure Holdings Corp. (the “
Company” or
“
Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of
intraoperative neuromonitoring services (“
IONM”),
has promoted Craig Caviness to vice president of corporate
development from his former role as eastern U.S. territory
director. In his new position, Caviness will be responsible for
directing all aspects of the Company’s hospital offering, through
which Assure will provide outsourced IONM services for entire
medical facilities. In addition, Caviness will serve as a team
member on Assure’s mergers and acquisitions, research and
innovation and operational performance teams.
“Craig’s wide experience in the healthcare space has been
instrumental in providing a broad perspective that has driven
contributions across the Company’s organic growth initiatives,”
said John A. Farlinger, Assure’s executive chairman and CEO.
“Craig’s primary function in his expanded role will be advancing
the Company’s proposition to hospitals for outsourcing their IONM
service needs to Assure. We anticipate winning these larger deals
that could generate thousands of procedures annually as many
hospitals transition to outsourcing IONM, which for them is a
non-core service and a cost center. We believe that under Craig’s
leadership, Assure’s hospital offering will be an important growth
driver in 2021 and beyond.”
A doctor of chiropractic and highly experienced intraoperative
neurophysiologist technologist, Caviness joined Assure in 2018. In
this role, he has been responsible for clinical operations in half
of the markets within Assure’s eight state operational footprint
and has driven business development including account initiation
and support. Prior to joining Assure he worked as a regional
president at IONM provider Medsurant Health where Caviness oversaw
a team of clinical supervisors, recruited technologists, optimized
clinical operations and was an instrumental team member in driving
corporate development initiatives relating to mergers and
acquisitions, high opportunity targeting and sales. Caviness
graduated from the State University of New York at Albany with a
bachelor of science in biology, earned a doctor of chiropractic
from New York Chiropractic College and is pursuing a master’s of
business administration from the University of Massachusetts at
Lowell.
On his appointment, Caviness commented, “It’s exciting to be
part of Assure’s leadership team as the Company enters a new phase
of expansion. I am focused on helping Assure achieve its objectives
with our hospital offering as my primary area of focus.”
About Assure HoldingsAssure Holdings Corp. is a
Colorado-based company that works with neurosurgeons and orthopedic
spine surgeons to provide a turnkey suite of services that support
intraoperative neuromonitoring activities during invasive
surgeries. Assure employs its own staff of technologists and uses
its own state-of-the-art monitoring equipment, handles 100% of
intraoperative neuromonitoring scheduling and setup, and bills for
all technical services provided. Assure Neuromonitoring is
recognized as providing the highest level of patient care in the
industry and has earned the Joint Commission’s Gold Seal of
Approval®. For more information, visit the company’s website
at www.assureneuromonitoring.com.
Forward-Looking StatementsThis news release may
contain “forward-looking statements” within the meaning of
applicable securities laws, including but not limited to: comments
with respect to strategies; expectations; planned operations;
future actions of the Company; the Company’s growth potential; the
ability of the Company to win larger contracts to provide its
services to hospitals and that these larger contracts will generate
thousands of IONM procedures on an annual basis; that the
appointment of Caviness will allow Assure to expand its hospital
offering; and that Assure’s hospital offering will be an important
growth driver in 2021 and beyond. Forward-looking statements may
generally be identified by the use of the words "anticipates,"
"expects," "intends," "plans," "should," "could," "would," "may,"
"will," "believes," "estimates," "potential," "target," or
"continue" and variations or similar expressions. These statements
are based upon the current expectations and beliefs of management
and are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include,
but are not limited to: the uncertainty surrounding the spread of
COVID-19 and the impact it will have on the Company’s operations
and economic activity in general, that the Company’s actions taken
during the COVID-19 health crisis will be effective, the Company’s
ability to continue to expand into other markets, the Company may
not realize its growth potential, the Company may not win larger
contracts to provide its services to hospitals and these larger
contracts may not generate thousands of IONM procedures on an
annual basis, the appointment of Caviness may not allow Assure to
expand its hospital offering, Assure’s hospital offering may not be
an important growth driver in 2021 and beyond, the risks and
uncertainties discussed in our most recent annual and quarterly
reports filed with the Canadian securities regulators and available
on the Company’s profile on SEDAR at www.sedar.com, which risks and
uncertainties are incorporated herein by reference. Readers are
cautioned not to place undue reliance on forward-looking
statements. Except as required by law, Assure does not intend, and
undertakes no obligation, to update any forward-looking statements
to reflect, in particular, new information or future events.Neither
the TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
ContactScott Kozak, Investor and Media
RelationsAssure Holdings
Corp.1-720-287-3093Scott.Kozak@assureiom.com
Assure (TSXV:IOM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Assure (TSXV:IOM)
Historical Stock Chart
From Oct 2023 to Oct 2024